skip to navigation skip to content

Personalised medicine


Sano Genetics, supported by Accelerate Cambridge at Cambridge Judge Business School, raises £500,000 seed funding for its ‘transparent’ medical research platform.

Personalised medicine

Sano Genetics, a Cambridge-based startup supported by the Cambridge Judge Entrepreneurship Centre through its Accelerate Cambridge programme, has raised £500,000 seed funding for its personalised medicine research platform.

Sano’s platform powers research into common disorders such as diabetes, eczema and depression, as well as muscular dystrophy and other rare diseases.

The company, formerly known as Heterogeneous, has had 1,500 participants in its first year and aims to enrol more than 10,000 people by the end of the year. The company’s “transparent” platform empowers users by ensuring they remain in control of their DNA data.

“We are passionate about the potential for personalised medicine based on genetic and health data,” said Patrick Short, CEO of Sano Genetics. “Our platform allows scientists to do research into personalised medicine, and access dynamic health and genetic data sets, while still giving individuals transparency and control throughout the process.”